tiprankstipranks
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH

Compare Aurinia Pharmaceuticals (AUPH) vs. Competitors

2,112 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Aurinia Pharmaceuticals
$15.79
$2.10B
7.46
108.04%
2 Buy
2 Hold
0 Sell
Moderate Buy
BioCryst
$9.59
$2.41B
6.20
41.24%
8 Buy
0 Hold
0 Sell
Strong Buy
Celldex
$31.35
$2.09B
-6.98
99.30%
10 Buy
1 Hold
1 Sell
Strong Buy
MannKind
$2.57
$791.82M
-27.17
-45.20%
6 Buy
1 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$23.08
$2.42B
-3.16
-55.95%
7 Buy
13 Hold
5 Sell
Hold
Immunocore Holdings
$31.96
$1.62B
-19.61
21.61%
6 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AUPH
Aurinia Pharmaceuticals
15.79
8.18
107.49%
BCRX
BioCryst
9.59
2.82
41.65%
CLDX
Celldex
31.35
14.94
91.04%
MNKD
MannKind
2.57
-2.12
-45.20%
SRPT
Sarepta Therapeutics
23.08
-32.57
-58.53%
IMCR
Immunocore Holdings
31.96
5.84
22.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts